Michael Adamzik

from Wikipedia, the free encyclopedia

Michael Adamzik (born July 10, 1971 in Gelsenkirchen ) is a German anesthetist and intensive care physician . Since May 1, 2013, he has been director of the Clinic for Anaesthesiology, Intensive Care Medicine and Pain Therapy at the University Clinic Knappschaftskrankenhaus Bochum , a clinic of the Ruhr University Bochum .

Life

Michael Adamzik ​​graduated from high school in Gelsenkirchen in 1991. This was followed by medical studies at the Ruhr University in Bochum and at the University of Duisburg-Essen , which he completed in 1999. He completed his practical year at the Mayo Clinic in Rochester, Minnesota , USA. After completing his medical degree, he completed his specialist training in anesthesiology at the Clinic for Anaesthesiology and Intensive Care Medicine at the University Hospital Essen. Here he also acquired the additional qualifications for intensive care medicine , emergency medicine and pain therapy . He completed his doctorate in medicine in 2002. After intensive research he received the Venia legendi for the subject anesthesiology in 2010 with his habilitation thesis "Molecular biological, functional and phenotypic characterization of a genetic polymorphism in the promoter of the gene AQP5". The appointment as adjunct professor took place in 2012 in Essen. In 2013 he accepted the chair for anesthesiology at the Ruhr University Bochum at the University Clinic Knappschaftskrankenhaus Bochum . Since then, he has been director of the Clinic for Anaesthesiology, Intensive Care Medicine and Pain Therapy and is currently Deputy Medical Director of the University Clinic Knappschaftskrankenhaus Bochum.

Research activity

Michael Adamzik's research focuses on the diagnosis and treatment of sepsis and acute lung failure . He is the initiator of SepsisDataNet.NRW, a cross-clinic research project to improve the diagnosis and treatment of sepsis, which is funded by the state of North Rhine-Westphalia and the European Union .

Awards

  • 2009 - DGAI research grant from the Fresenius Foundation
  • 2011 - Roger Bone Prize of the German Sepsis Society

Memberships and chairs

Publications (selected)

Studies

  • with UH Frey, K. Rieman, S. Sixt, M. Beiderlinden, W. Siffert and J. Peters: Insertion / deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. In: Intensive Care Med. 33 (7), 2007, pp. 1199-1203.
  • with M. Eggmann, UH Frey, K. Görlinger, M. Bröcker-Preuss, G. Marggraf, F. Saner, H. Eggebrecht, J. Peters and M. Hartmann: Comparison of thromboelastometry with procalcitonin, interleukin 6, and C- reactive protein as diagnostic tests for severe sepsis in critically ill adults. In: Crit Care. 14 (5), 2010, R178.
  • with UH Frey, S. Möhlenkamp, ​​A. Scherag, C. Waydhas, G. Marggraf, M. Dammann, J. Steinmann, W. Siffert, and J. Peters: Aquaporin 5 gene promoter - 1364A / C polymorphism associated with 30 -day survival in severe sepsis. In: Anesthesiology. 114 (4), 2011, pp. 912-917.
  • with T. Langemeier, UH Frey, K. Görlinger, F. Saner, H. Eggebrecht, J. Peters and M. Hartmann : Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. In: Shock. 35 (4), 2011, pp. 339-342.
  • with K. Görlinger, J. Peters and M. Hartmann: Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis. In: Crit Care. 16 (5), 2012, R204.
  • with T. Hamburger, F. Petrat, J. Peters, H. de Groot and M. Hartmann: Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome. In: Crit Care. 16 (4), 2012, R125.
  • with J. Broll, J. Steinmann, AM Westendorf, I. Rehfeld, C. Kreissig and J. Peters: An increased alveolar CD4 + CD25 + Foxp3 + T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality. In: Intensive Care Med. 39 (10), 2013, pp. 1743–1751.
  • with S. Schäfer, UH Frey, A. Becker, M. Kreuzer, S. Winning, S. Frede, J. Steinmann, J. Fandrey, K. Zacharowski, W. Siffert, J. Peters and M. Hartmann: The NFKB1 promoter polymorphism (-94ins / delATTG) alters nuclear translocation of NF-κB1 in monocytes after lipopolysaccharide stimulation and is associated with increased mortality in sepsis. In: Anesthesiology. 118 (1), 2013, pp. 123-133.

Trade journals (editorial board)

Web links

Individual evidence

  1. ^ University Hospital of the Ruhr University Bochum: Professor Michael Adamzik ​​introduced as director. Retrieved July 5, 2018 .
  2. ^ German Society for Anaesthesiology and Intensive Care Medicine eV: DGAI research grant. Retrieved July 5, 2018 .
  3. ^ Deutsche Sepsis-Gesellschaft eV: Prize winners. Retrieved July 5, 2018 .
  4. ^ Paul Ehrlich Society for Chemotherapy eV: Working groups. Retrieved July 5, 2018 .
personal data
SURNAME Adamzik, Michael
BRIEF DESCRIPTION German anesthetist and intensive care physician
DATE OF BIRTH July 10, 1971
PLACE OF BIRTH Gelsenkirchen